2018-2023 Global DTaP and Tdap Vaccines Consumption Market Report
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global DTaP and Tdap Vaccines market for 2018-2023.
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free environment. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis. According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. In 2015, procurement of DTwP vaccine through UNICEF had reached 5.8 million doses for 18 countries and territories out of which four countries such as Egypt, Morocco, Uzbekistan, and Zimbabwe accounted for more than 80% of UNICEF’s total procurement.
Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.
The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%–85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.
Over the next five years, LPI(LP Information) projects that DTaP and Tdap Vaccines will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of DTaP and Tdap Vaccines market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global DTaP and Tdap Vaccines market for 2018-2023.
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free environment. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis. According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. In 2015, procurement of DTwP vaccine through UNICEF had reached 5.8 million doses for 18 countries and territories out of which four countries such as Egypt, Morocco, Uzbekistan, and Zimbabwe accounted for more than 80% of UNICEF’s total procurement.
Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.
The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%–85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.
Over the next five years, LPI(LP Information) projects that DTaP and Tdap Vaccines will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of DTaP and Tdap Vaccines market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- DTaP
- Td
- Tdap
- Adult
- Pediatric
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur
- GlaxoSmithKline
- Protein Sciences Corporation
- Novartis AG
- Seqirus
- Merck Sharp & Dohme Corp
- Astellas Pharma US, Inc
- Pfizer Inc
- Johnson & Johnson
- Lanzhou Institute of Biological Products Co., Ltd
- AstraZeneca
- Emergent BioSolutions Inc
Research objectives
- To study and analyze the global DTaP and Tdap Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of DTaP and Tdap Vaccines market by identifying its various subsegments.
- Focuses on the key global DTaP and Tdap Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the DTaP and Tdap Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of DTaP and Tdap Vaccines submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global DTaP and Tdap Vaccines Consumption 2013-2023
2.1.2 DTaP and Tdap Vaccines Consumption CAGR by Region
2.2 DTaP and Tdap Vaccines Segment by Type
2.2.1 DTaP
2.2.2 Td
2.2.3 Tdap
2.3 DTaP and Tdap Vaccines Consumption by Type
2.3.1 Global DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
2.3.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Type (2013-2018)
2.3.3 Global DTaP and Tdap Vaccines Sale Price by Type (2013-2018)
2.4 DTaP and Tdap Vaccines Segment by Application
2.4.1 Adult
2.4.2 Pediatric
2.5 DTaP and Tdap Vaccines Consumption by Application
2.5.1 Global DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
2.5.2 Global DTaP and Tdap Vaccines Value and Market Share by Application (2013-2018)
2.5.3 Global DTaP and Tdap Vaccines Sale Price by Application (2013-2018)
3 GLOBAL DTAP AND TDAP VACCINES BY PLAYERS
3.1 Global DTaP and Tdap Vaccines Sales Market Share by Players
3.1.1 Global DTaP and Tdap Vaccines Sales by Players (2016-2018)
3.1.2 Global DTaP and Tdap Vaccines Sales Market Share by Players (2016-2018)
3.2 Global DTaP and Tdap Vaccines Revenue Market Share by Players
3.2.1 Global DTaP and Tdap Vaccines Revenue by Players (2016-2018)
3.2.2 Global DTaP and Tdap Vaccines Revenue Market Share by Players (2016-2018)
3.3 Global DTaP and Tdap Vaccines Sale Price by Players
3.4 Global DTaP and Tdap Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global DTaP and Tdap Vaccines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players DTaP and Tdap Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 DTAP AND TDAP VACCINES BY REGIONS
4.1 DTaP and Tdap Vaccines by Regions
4.1.1 Global DTaP and Tdap Vaccines Consumption by Regions
4.1.2 Global DTaP and Tdap Vaccines Value by Regions
4.2 Americas DTaP and Tdap Vaccines Consumption Growth
4.3 APAC DTaP and Tdap Vaccines Consumption Growth
4.4 Europe DTaP and Tdap Vaccines Consumption Growth
4.5 Middle East & Africa DTaP and Tdap Vaccines Consumption Growth
5 AMERICAS
5.1 Americas DTaP and Tdap Vaccines Consumption by Countries
5.1.1 Americas DTaP and Tdap Vaccines Consumption by Countries (2013-2018)
5.1.2 Americas DTaP and Tdap Vaccines Value by Countries (2013-2018)
5.2 Americas DTaP and Tdap Vaccines Consumption by Type
5.3 Americas DTaP and Tdap Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC DTaP and Tdap Vaccines Consumption by Countries
6.1.1 APAC DTaP and Tdap Vaccines Consumption by Countries (2013-2018)
6.1.2 APAC DTaP and Tdap Vaccines Value by Countries (2013-2018)
6.2 APAC DTaP and Tdap Vaccines Consumption by Type
6.3 APAC DTaP and Tdap Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe DTaP and Tdap Vaccines by Countries
7.1.1 Europe DTaP and Tdap Vaccines Consumption by Countries (2013-2018)
7.1.2 Europe DTaP and Tdap Vaccines Value by Countries (2013-2018)
7.2 Europe DTaP and Tdap Vaccines Consumption by Type
7.3 Europe DTaP and Tdap Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa DTaP and Tdap Vaccines by Countries
8.1.1 Middle East & Africa DTaP and Tdap Vaccines Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa DTaP and Tdap Vaccines Value by Countries (2013-2018)
8.2 Middle East & Africa DTaP and Tdap Vaccines Consumption by Type
8.3 Middle East & Africa DTaP and Tdap Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 DTaP and Tdap Vaccines Distributors
10.3 DTaP and Tdap Vaccines Customer
11 GLOBAL DTAP AND TDAP VACCINES MARKET FORECAST
11.1 Global DTaP and Tdap Vaccines Consumption Forecast (2018-2023)
11.2 Global DTaP and Tdap Vaccines Forecast by Regions
11.2.1 Global DTaP and Tdap Vaccines Forecast by Regions (2018-2023)
11.2.2 Global DTaP and Tdap Vaccines Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global DTaP and Tdap Vaccines Forecast by Type
11.8 Global DTaP and Tdap Vaccines Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Sanofi Pasteur
12.1.1 Company Details
12.1.2 DTaP and Tdap Vaccines Product Offered
12.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Sanofi Pasteur News
12.2 GlaxoSmithKline
12.2.1 Company Details
12.2.2 DTaP and Tdap Vaccines Product Offered
12.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 GlaxoSmithKline News
12.3 Protein Sciences Corporation
12.3.1 Company Details
12.3.2 DTaP and Tdap Vaccines Product Offered
12.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Protein Sciences Corporation News
12.4 Novartis AG
12.4.1 Company Details
12.4.2 DTaP and Tdap Vaccines Product Offered
12.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Novartis AG News
12.5 Seqirus
12.5.1 Company Details
12.5.2 DTaP and Tdap Vaccines Product Offered
12.5.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Seqirus News
12.6 Merck Sharp & Dohme Corp
12.6.1 Company Details
12.6.2 DTaP and Tdap Vaccines Product Offered
12.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Merck Sharp & Dohme Corp News
12.7 Astellas Pharma US, Inc
12.7.1 Company Details
12.7.2 DTaP and Tdap Vaccines Product Offered
12.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Astellas Pharma US, Inc News
12.8 Pfizer Inc
12.8.1 Company Details
12.8.2 DTaP and Tdap Vaccines Product Offered
12.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Pfizer Inc News
12.9 Johnson & Johnson
12.9.1 Company Details
12.9.2 DTaP and Tdap Vaccines Product Offered
12.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Johnson & Johnson News
12.10 Lanzhou Institute of Biological Products Co., Ltd
12.10.1 Company Details
12.10.2 DTaP and Tdap Vaccines Product Offered
12.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Lanzhou Institute of Biological Products Co., Ltd News
12.11 AstraZeneca
12.12 Emergent BioSolutions Inc
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global DTaP and Tdap Vaccines Consumption 2013-2023
2.1.2 DTaP and Tdap Vaccines Consumption CAGR by Region
2.2 DTaP and Tdap Vaccines Segment by Type
2.2.1 DTaP
2.2.2 Td
2.2.3 Tdap
2.3 DTaP and Tdap Vaccines Consumption by Type
2.3.1 Global DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
2.3.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Type (2013-2018)
2.3.3 Global DTaP and Tdap Vaccines Sale Price by Type (2013-2018)
2.4 DTaP and Tdap Vaccines Segment by Application
2.4.1 Adult
2.4.2 Pediatric
2.5 DTaP and Tdap Vaccines Consumption by Application
2.5.1 Global DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
2.5.2 Global DTaP and Tdap Vaccines Value and Market Share by Application (2013-2018)
2.5.3 Global DTaP and Tdap Vaccines Sale Price by Application (2013-2018)
3 GLOBAL DTAP AND TDAP VACCINES BY PLAYERS
3.1 Global DTaP and Tdap Vaccines Sales Market Share by Players
3.1.1 Global DTaP and Tdap Vaccines Sales by Players (2016-2018)
3.1.2 Global DTaP and Tdap Vaccines Sales Market Share by Players (2016-2018)
3.2 Global DTaP and Tdap Vaccines Revenue Market Share by Players
3.2.1 Global DTaP and Tdap Vaccines Revenue by Players (2016-2018)
3.2.2 Global DTaP and Tdap Vaccines Revenue Market Share by Players (2016-2018)
3.3 Global DTaP and Tdap Vaccines Sale Price by Players
3.4 Global DTaP and Tdap Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global DTaP and Tdap Vaccines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players DTaP and Tdap Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 DTAP AND TDAP VACCINES BY REGIONS
4.1 DTaP and Tdap Vaccines by Regions
4.1.1 Global DTaP and Tdap Vaccines Consumption by Regions
4.1.2 Global DTaP and Tdap Vaccines Value by Regions
4.2 Americas DTaP and Tdap Vaccines Consumption Growth
4.3 APAC DTaP and Tdap Vaccines Consumption Growth
4.4 Europe DTaP and Tdap Vaccines Consumption Growth
4.5 Middle East & Africa DTaP and Tdap Vaccines Consumption Growth
5 AMERICAS
5.1 Americas DTaP and Tdap Vaccines Consumption by Countries
5.1.1 Americas DTaP and Tdap Vaccines Consumption by Countries (2013-2018)
5.1.2 Americas DTaP and Tdap Vaccines Value by Countries (2013-2018)
5.2 Americas DTaP and Tdap Vaccines Consumption by Type
5.3 Americas DTaP and Tdap Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC DTaP and Tdap Vaccines Consumption by Countries
6.1.1 APAC DTaP and Tdap Vaccines Consumption by Countries (2013-2018)
6.1.2 APAC DTaP and Tdap Vaccines Value by Countries (2013-2018)
6.2 APAC DTaP and Tdap Vaccines Consumption by Type
6.3 APAC DTaP and Tdap Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe DTaP and Tdap Vaccines by Countries
7.1.1 Europe DTaP and Tdap Vaccines Consumption by Countries (2013-2018)
7.1.2 Europe DTaP and Tdap Vaccines Value by Countries (2013-2018)
7.2 Europe DTaP and Tdap Vaccines Consumption by Type
7.3 Europe DTaP and Tdap Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa DTaP and Tdap Vaccines by Countries
8.1.1 Middle East & Africa DTaP and Tdap Vaccines Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa DTaP and Tdap Vaccines Value by Countries (2013-2018)
8.2 Middle East & Africa DTaP and Tdap Vaccines Consumption by Type
8.3 Middle East & Africa DTaP and Tdap Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 DTaP and Tdap Vaccines Distributors
10.3 DTaP and Tdap Vaccines Customer
11 GLOBAL DTAP AND TDAP VACCINES MARKET FORECAST
11.1 Global DTaP and Tdap Vaccines Consumption Forecast (2018-2023)
11.2 Global DTaP and Tdap Vaccines Forecast by Regions
11.2.1 Global DTaP and Tdap Vaccines Forecast by Regions (2018-2023)
11.2.2 Global DTaP and Tdap Vaccines Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global DTaP and Tdap Vaccines Forecast by Type
11.8 Global DTaP and Tdap Vaccines Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Sanofi Pasteur
12.1.1 Company Details
12.1.2 DTaP and Tdap Vaccines Product Offered
12.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Sanofi Pasteur News
12.2 GlaxoSmithKline
12.2.1 Company Details
12.2.2 DTaP and Tdap Vaccines Product Offered
12.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 GlaxoSmithKline News
12.3 Protein Sciences Corporation
12.3.1 Company Details
12.3.2 DTaP and Tdap Vaccines Product Offered
12.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Protein Sciences Corporation News
12.4 Novartis AG
12.4.1 Company Details
12.4.2 DTaP and Tdap Vaccines Product Offered
12.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Novartis AG News
12.5 Seqirus
12.5.1 Company Details
12.5.2 DTaP and Tdap Vaccines Product Offered
12.5.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Seqirus News
12.6 Merck Sharp & Dohme Corp
12.6.1 Company Details
12.6.2 DTaP and Tdap Vaccines Product Offered
12.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Merck Sharp & Dohme Corp News
12.7 Astellas Pharma US, Inc
12.7.1 Company Details
12.7.2 DTaP and Tdap Vaccines Product Offered
12.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Astellas Pharma US, Inc News
12.8 Pfizer Inc
12.8.1 Company Details
12.8.2 DTaP and Tdap Vaccines Product Offered
12.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Pfizer Inc News
12.9 Johnson & Johnson
12.9.1 Company Details
12.9.2 DTaP and Tdap Vaccines Product Offered
12.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Johnson & Johnson News
12.10 Lanzhou Institute of Biological Products Co., Ltd
12.10.1 Company Details
12.10.2 DTaP and Tdap Vaccines Product Offered
12.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Lanzhou Institute of Biological Products Co., Ltd News
12.11 AstraZeneca
12.12 Emergent BioSolutions Inc
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of DTaP and Tdap Vaccines
Table Product Specifications of DTaP and Tdap Vaccines
Figure DTaP and Tdap Vaccines Report Years Considered
Figure Market Research Methodology
Figure Global DTaP and Tdap Vaccines Consumption Growth Rate 2013-2023 (K Units)
Figure Global DTaP and Tdap Vaccines Value Growth Rate 2013-2023 ($ Millions)
Table DTaP and Tdap Vaccines Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of DTaP
Table Major Players of DTaP
Figure Product Picture of Td
Table Major Players of Td
Figure Product Picture of Tdap
Table Major Players of Tdap
Table Global Consumption Sales by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Figure Global DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue by Type (2013-2018) ($ million)
Table Global DTaP and Tdap Vaccines Value Market Share by Type (2013-2018) ($ Millions)
Figure Global DTaP and Tdap Vaccines Value Market Share by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Sale Price by Type (2013-2018)
Figure DTaP and Tdap Vaccines Consumed in Adult
Figure Global DTaP and Tdap Vaccines Market: Adult (2013-2018) (K Units)
Figure Global DTaP and Tdap Vaccines Market: Adult (2013-2018) ($ Millions)
Figure Global Adult YoY Growth ($ Millions)
Figure DTaP and Tdap Vaccines Consumed in Pediatric
Figure Global DTaP and Tdap Vaccines Market: Pediatric (2013-2018) (K Units)
Figure Global DTaP and Tdap Vaccines Market: Pediatric (2013-2018) ($ Millions)
Figure Global Pediatric YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Figure Global DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Value by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Value Market Share by Application (2013-2018)
Figure Global DTaP and Tdap Vaccines Value Market Share by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Sale Price by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Sales by Players (2016-2018) (K Units)
Table Global DTaP and Tdap Vaccines Sales Market Share by Players (2016-2018)
Figure Global DTaP and Tdap Vaccines Sales Market Share by Players in 2016
Figure Global DTaP and Tdap Vaccines Sales Market Share by Players in 2017
Table Global DTaP and Tdap Vaccines Revenue by Players (2016-2018) ($ Millions)
Table Global DTaP and Tdap Vaccines Revenue Market Share by Players (2016-2018)
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Players in 2016
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Players in 2017
Table Global DTaP and Tdap Vaccines Sale Price by Players (2016-2018)
Figure Global DTaP and Tdap Vaccines Sale Price by Players in 2017
Table Global DTaP and Tdap Vaccines Manufacturing Base Distribution and Sales Area by Players
Table Players DTaP and Tdap Vaccines Products Offered
Table DTaP and Tdap Vaccines Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global DTaP and Tdap Vaccines Consumption by Regions 2013-2018 (K Units)
Table Global DTaP and Tdap Vaccines Consumption Market Share by Regions 2013-2018
Figure Global DTaP and Tdap Vaccines Consumption Market Share by Regions 2013-2018
Table Global DTaP and Tdap Vaccines Value by Regions 2013-2018 ($ Millions)
Table Global DTaP and Tdap Vaccines Value Market Share by Regions 2013-2018
Figure Global DTaP and Tdap Vaccines Value Market Share by Regions 2013-2018
Figure Americas DTaP and Tdap Vaccines Consumption 2013-2018 (K Units)
Figure Americas DTaP and Tdap Vaccines Value 2013-2018 ($ Millions)
Figure APAC DTaP and Tdap Vaccines Consumption 2013-2018 (K Units)
Figure APAC DTaP and Tdap Vaccines Value 2013-2018 ($ Millions)
Figure Europe DTaP and Tdap Vaccines Consumption 2013-2018 (K Units)
Figure Europe DTaP and Tdap Vaccines Value 2013-2018 ($ Millions)
Figure Middle East & Africa DTaP and Tdap Vaccines Consumption 2013-2018 (K Units)
Figure Middle East & Africa DTaP and Tdap Vaccines Value 2013-2018 ($ Millions)
Table Americas DTaP and Tdap Vaccines Consumption by Countries (2013-2018) (K Units)
Table Americas DTaP and Tdap Vaccines Consumption Market Share by Countries (2013-2018)
Figure Americas DTaP and Tdap Vaccines Consumption Market Share by Countries in 2017
Table Americas DTaP and Tdap Vaccines Value by Countries (2013-2018) ($ Millions)
Table Americas DTaP and Tdap Vaccines Value Market Share by Countries (2013-2018)
Figure Americas DTaP and Tdap Vaccines Value Market Share by Countries in 2017
Table Americas DTaP and Tdap Vaccines Consumption by Type (2013-2018) (K Units)
Table Americas DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Figure Americas DTaP and Tdap Vaccines Consumption Market Share by Type in 2017
Table Americas DTaP and Tdap Vaccines Consumption by Application (2013-2018) (K Units)
Table Americas DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Figure Americas DTaP and Tdap Vaccines Consumption Market Share by Application in 2017
Figure United States DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure United States DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Canada DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Canada DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Mexico DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Mexico DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Table APAC DTaP and Tdap Vaccines Consumption by Countries (2013-2018) (K Units)
Table APAC DTaP and Tdap Vaccines Consumption Market Share by Countries (2013-2018)
Figure APAC DTaP and Tdap Vaccines Consumption Market Share by Countries in 2017
Table APAC DTaP and Tdap Vaccines Value by Countries (2013-2018) ($ Millions)
Table APAC DTaP and Tdap Vaccines Value Market Share by Countries (2013-2018)
Figure APAC DTaP and Tdap Vaccines Value Market Share by Countries in 2017
Table APAC DTaP and Tdap Vaccines Consumption by Type (2013-2018) (K Units)
Table APAC DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Figure APAC DTaP and Tdap Vaccines Consumption Market Share by Type in 2017
Table APAC DTaP and Tdap Vaccines Consumption by Application (2013-2018) (K Units)
Table APAC DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Figure APAC DTaP and Tdap Vaccines Consumption Market Share by Application in 2017
Figure China DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure China DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Japan DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Japan DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Korea DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Korea DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure India DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure India DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Australia DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Australia DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Table Europe DTaP and Tdap Vaccines Consumption by Countries (2013-2018) (K Units)
Table Europe DTaP and Tdap Vaccines Consumption Market Share by Countries (2013-2018)
Figure Europe DTaP and Tdap Vaccines Consumption Market Share by Countries in 2017
Table Europe DTaP and Tdap Vaccines Value by Countries (2013-2018) ($ Millions)
Table Europe DTaP and Tdap Vaccines Value Market Share by Countries (2013-2018)
Figure Europe DTaP and Tdap Vaccines Value Market Share by Countries in 2017
Table Europe DTaP and Tdap Vaccines Consumption by Type (2013-2018) (K Units)
Table Europe DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Figure Europe DTaP and Tdap Vaccines Consumption Market Share by Type in 2017
Table Europe DTaP and Tdap Vaccines Consumption by Application (2013-2018) (K Units)
Table Europe DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Figure Europe DTaP and Tdap Vaccines Consumption Market Share by Application in 2017
Figure Germany DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Germany DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure France DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure France DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure UK DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure UK DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Italy DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Italy DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Russia DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Russia DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Spain DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Spain DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa DTaP and Tdap Vaccines Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Countries in 2017
Table Middle East & Africa DTaP and Tdap Vaccines Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa DTaP and Tdap Vaccines Value Market Share by Countries (2013-2018)
Figure Middle East & Africa DTaP and Tdap Vaccines Value Market Share by Countries in 2017
Table Middle East & Africa DTaP and Tdap Vaccines Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Type in 2017
Table Middle East & Africa DTaP and Tdap Vaccines Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Application in 2017
Figure Egypt DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Egypt DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure South Africa DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure South Africa DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Israel DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Israel DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Turkey DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Turkey DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure GCC Countries DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure GCC Countries DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Table DTaP and Tdap Vaccines Distributors List
Table DTaP and Tdap Vaccines Customer List
Figure Global DTaP and Tdap Vaccines Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global DTaP and Tdap Vaccines Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global DTaP and Tdap Vaccines Consumption Forecast by Countries (2018-2023) (K Units)
Table Global DTaP and Tdap Vaccines Consumption Market Forecast by Regions
Table Global DTaP and Tdap Vaccines Value Forecast by Countries (2018-2023) ($ Millions)
Table Global DTaP and Tdap Vaccines Value Market Share Forecast by Regions
Figure Americas DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Americas DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure APAC DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure APAC DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Europe DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Europe DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Middle East & Africa DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Middle East & Africa DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure United States DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure United States DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Canada DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Canada DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Mexico DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Mexico DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Brazil DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Brazil DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure China DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure China DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Japan DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Japan DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Korea DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Korea DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Southeast Asia DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Southeast Asia DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure India DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure India DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Australia DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Australia DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Germany DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Germany DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure France DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure France DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure UK DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure UK DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Italy DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Italy DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Russia DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Russia DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Spain DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Spain DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Egypt DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Egypt DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure South Africa DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure South Africa DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Israel DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Israel DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Turkey DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Turkey DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure GCC Countries DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure GCC Countries DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Table Global DTaP and Tdap Vaccines Consumption Forecast by Type (2018-2023) (K Units)
Table Global DTaP and Tdap Vaccines Consumption Market Share Forecast by Type (2018-2023)
Table Global DTaP and Tdap Vaccines Value Forecast by Type (2018-2023) ($ Millions)
Table Global DTaP and Tdap Vaccines Value Market Share Forecast by Type (2018-2023)
Table Global DTaP and Tdap Vaccines Consumption Forecast by Application (2018-2023) (K Units)
Table Global DTaP and Tdap Vaccines Consumption Market Share Forecast by Application (2018-2023)
Table Global DTaP and Tdap Vaccines Value Forecast by Application (2018-2023) ($ Millions)
Table Global DTaP and Tdap Vaccines Value Market Share Forecast by Application (2018-2023)
Table Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Pasteur DTaP and Tdap Vaccines Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline DTaP and Tdap Vaccines Market Share (2016-2018)
Table Protein Sciences Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Protein Sciences Corporation DTaP and Tdap Vaccines Market Share (2016-2018)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis AG DTaP and Tdap Vaccines Market Share (2016-2018)
Table Seqirus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seqirus DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Seqirus DTaP and Tdap Vaccines Market Share (2016-2018)
Table Merck Sharp & Dohme Corp Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Market Share (2016-2018)
Table Astellas Pharma US, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astellas Pharma US, Inc DTaP and Tdap Vaccines Market Share (2016-2018)
Table Pfizer Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Inc DTaP and Tdap Vaccines Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson DTaP and Tdap Vaccines Market Share (2016-2018)
Table Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent BioSolutions Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure Picture of DTaP and Tdap Vaccines
Table Product Specifications of DTaP and Tdap Vaccines
Figure DTaP and Tdap Vaccines Report Years Considered
Figure Market Research Methodology
Figure Global DTaP and Tdap Vaccines Consumption Growth Rate 2013-2023 (K Units)
Figure Global DTaP and Tdap Vaccines Value Growth Rate 2013-2023 ($ Millions)
Table DTaP and Tdap Vaccines Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of DTaP
Table Major Players of DTaP
Figure Product Picture of Td
Table Major Players of Td
Figure Product Picture of Tdap
Table Major Players of Tdap
Table Global Consumption Sales by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Figure Global DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue by Type (2013-2018) ($ million)
Table Global DTaP and Tdap Vaccines Value Market Share by Type (2013-2018) ($ Millions)
Figure Global DTaP and Tdap Vaccines Value Market Share by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Sale Price by Type (2013-2018)
Figure DTaP and Tdap Vaccines Consumed in Adult
Figure Global DTaP and Tdap Vaccines Market: Adult (2013-2018) (K Units)
Figure Global DTaP and Tdap Vaccines Market: Adult (2013-2018) ($ Millions)
Figure Global Adult YoY Growth ($ Millions)
Figure DTaP and Tdap Vaccines Consumed in Pediatric
Figure Global DTaP and Tdap Vaccines Market: Pediatric (2013-2018) (K Units)
Figure Global DTaP and Tdap Vaccines Market: Pediatric (2013-2018) ($ Millions)
Figure Global Pediatric YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Figure Global DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Value by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Value Market Share by Application (2013-2018)
Figure Global DTaP and Tdap Vaccines Value Market Share by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Sale Price by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Sales by Players (2016-2018) (K Units)
Table Global DTaP and Tdap Vaccines Sales Market Share by Players (2016-2018)
Figure Global DTaP and Tdap Vaccines Sales Market Share by Players in 2016
Figure Global DTaP and Tdap Vaccines Sales Market Share by Players in 2017
Table Global DTaP and Tdap Vaccines Revenue by Players (2016-2018) ($ Millions)
Table Global DTaP and Tdap Vaccines Revenue Market Share by Players (2016-2018)
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Players in 2016
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Players in 2017
Table Global DTaP and Tdap Vaccines Sale Price by Players (2016-2018)
Figure Global DTaP and Tdap Vaccines Sale Price by Players in 2017
Table Global DTaP and Tdap Vaccines Manufacturing Base Distribution and Sales Area by Players
Table Players DTaP and Tdap Vaccines Products Offered
Table DTaP and Tdap Vaccines Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global DTaP and Tdap Vaccines Consumption by Regions 2013-2018 (K Units)
Table Global DTaP and Tdap Vaccines Consumption Market Share by Regions 2013-2018
Figure Global DTaP and Tdap Vaccines Consumption Market Share by Regions 2013-2018
Table Global DTaP and Tdap Vaccines Value by Regions 2013-2018 ($ Millions)
Table Global DTaP and Tdap Vaccines Value Market Share by Regions 2013-2018
Figure Global DTaP and Tdap Vaccines Value Market Share by Regions 2013-2018
Figure Americas DTaP and Tdap Vaccines Consumption 2013-2018 (K Units)
Figure Americas DTaP and Tdap Vaccines Value 2013-2018 ($ Millions)
Figure APAC DTaP and Tdap Vaccines Consumption 2013-2018 (K Units)
Figure APAC DTaP and Tdap Vaccines Value 2013-2018 ($ Millions)
Figure Europe DTaP and Tdap Vaccines Consumption 2013-2018 (K Units)
Figure Europe DTaP and Tdap Vaccines Value 2013-2018 ($ Millions)
Figure Middle East & Africa DTaP and Tdap Vaccines Consumption 2013-2018 (K Units)
Figure Middle East & Africa DTaP and Tdap Vaccines Value 2013-2018 ($ Millions)
Table Americas DTaP and Tdap Vaccines Consumption by Countries (2013-2018) (K Units)
Table Americas DTaP and Tdap Vaccines Consumption Market Share by Countries (2013-2018)
Figure Americas DTaP and Tdap Vaccines Consumption Market Share by Countries in 2017
Table Americas DTaP and Tdap Vaccines Value by Countries (2013-2018) ($ Millions)
Table Americas DTaP and Tdap Vaccines Value Market Share by Countries (2013-2018)
Figure Americas DTaP and Tdap Vaccines Value Market Share by Countries in 2017
Table Americas DTaP and Tdap Vaccines Consumption by Type (2013-2018) (K Units)
Table Americas DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Figure Americas DTaP and Tdap Vaccines Consumption Market Share by Type in 2017
Table Americas DTaP and Tdap Vaccines Consumption by Application (2013-2018) (K Units)
Table Americas DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Figure Americas DTaP and Tdap Vaccines Consumption Market Share by Application in 2017
Figure United States DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure United States DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Canada DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Canada DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Mexico DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Mexico DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Table APAC DTaP and Tdap Vaccines Consumption by Countries (2013-2018) (K Units)
Table APAC DTaP and Tdap Vaccines Consumption Market Share by Countries (2013-2018)
Figure APAC DTaP and Tdap Vaccines Consumption Market Share by Countries in 2017
Table APAC DTaP and Tdap Vaccines Value by Countries (2013-2018) ($ Millions)
Table APAC DTaP and Tdap Vaccines Value Market Share by Countries (2013-2018)
Figure APAC DTaP and Tdap Vaccines Value Market Share by Countries in 2017
Table APAC DTaP and Tdap Vaccines Consumption by Type (2013-2018) (K Units)
Table APAC DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Figure APAC DTaP and Tdap Vaccines Consumption Market Share by Type in 2017
Table APAC DTaP and Tdap Vaccines Consumption by Application (2013-2018) (K Units)
Table APAC DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Figure APAC DTaP and Tdap Vaccines Consumption Market Share by Application in 2017
Figure China DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure China DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Japan DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Japan DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Korea DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Korea DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure India DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure India DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Australia DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Australia DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Table Europe DTaP and Tdap Vaccines Consumption by Countries (2013-2018) (K Units)
Table Europe DTaP and Tdap Vaccines Consumption Market Share by Countries (2013-2018)
Figure Europe DTaP and Tdap Vaccines Consumption Market Share by Countries in 2017
Table Europe DTaP and Tdap Vaccines Value by Countries (2013-2018) ($ Millions)
Table Europe DTaP and Tdap Vaccines Value Market Share by Countries (2013-2018)
Figure Europe DTaP and Tdap Vaccines Value Market Share by Countries in 2017
Table Europe DTaP and Tdap Vaccines Consumption by Type (2013-2018) (K Units)
Table Europe DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Figure Europe DTaP and Tdap Vaccines Consumption Market Share by Type in 2017
Table Europe DTaP and Tdap Vaccines Consumption by Application (2013-2018) (K Units)
Table Europe DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Figure Europe DTaP and Tdap Vaccines Consumption Market Share by Application in 2017
Figure Germany DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Germany DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure France DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure France DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure UK DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure UK DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Italy DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Italy DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Russia DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Russia DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Spain DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Spain DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa DTaP and Tdap Vaccines Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Countries in 2017
Table Middle East & Africa DTaP and Tdap Vaccines Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa DTaP and Tdap Vaccines Value Market Share by Countries (2013-2018)
Figure Middle East & Africa DTaP and Tdap Vaccines Value Market Share by Countries in 2017
Table Middle East & Africa DTaP and Tdap Vaccines Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Type in 2017
Table Middle East & Africa DTaP and Tdap Vaccines Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa DTaP and Tdap Vaccines Consumption Market Share by Application in 2017
Figure Egypt DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Egypt DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure South Africa DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure South Africa DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Israel DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Israel DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure Turkey DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure Turkey DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Figure GCC Countries DTaP and Tdap Vaccines Consumption Growth 2013-2018 (K Units)
Figure GCC Countries DTaP and Tdap Vaccines Value Growth 2013-2018 ($ Millions)
Table DTaP and Tdap Vaccines Distributors List
Table DTaP and Tdap Vaccines Customer List
Figure Global DTaP and Tdap Vaccines Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global DTaP and Tdap Vaccines Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global DTaP and Tdap Vaccines Consumption Forecast by Countries (2018-2023) (K Units)
Table Global DTaP and Tdap Vaccines Consumption Market Forecast by Regions
Table Global DTaP and Tdap Vaccines Value Forecast by Countries (2018-2023) ($ Millions)
Table Global DTaP and Tdap Vaccines Value Market Share Forecast by Regions
Figure Americas DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Americas DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure APAC DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure APAC DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Europe DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Europe DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Middle East & Africa DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Middle East & Africa DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure United States DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure United States DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Canada DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Canada DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Mexico DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Mexico DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Brazil DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Brazil DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure China DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure China DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Japan DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Japan DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Korea DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Korea DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Southeast Asia DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Southeast Asia DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure India DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure India DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Australia DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Australia DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Germany DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Germany DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure France DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure France DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure UK DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure UK DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Italy DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Italy DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Russia DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Russia DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Spain DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Spain DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Egypt DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Egypt DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure South Africa DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure South Africa DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Israel DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Israel DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure Turkey DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure Turkey DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Figure GCC Countries DTaP and Tdap Vaccines Consumption 2018-2023 (K Units)
Figure GCC Countries DTaP and Tdap Vaccines Value 2018-2023 ($ Millions)
Table Global DTaP and Tdap Vaccines Consumption Forecast by Type (2018-2023) (K Units)
Table Global DTaP and Tdap Vaccines Consumption Market Share Forecast by Type (2018-2023)
Table Global DTaP and Tdap Vaccines Value Forecast by Type (2018-2023) ($ Millions)
Table Global DTaP and Tdap Vaccines Value Market Share Forecast by Type (2018-2023)
Table Global DTaP and Tdap Vaccines Consumption Forecast by Application (2018-2023) (K Units)
Table Global DTaP and Tdap Vaccines Consumption Market Share Forecast by Application (2018-2023)
Table Global DTaP and Tdap Vaccines Value Forecast by Application (2018-2023) ($ Millions)
Table Global DTaP and Tdap Vaccines Value Market Share Forecast by Application (2018-2023)
Table Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Pasteur DTaP and Tdap Vaccines Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline DTaP and Tdap Vaccines Market Share (2016-2018)
Table Protein Sciences Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Protein Sciences Corporation DTaP and Tdap Vaccines Market Share (2016-2018)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis AG DTaP and Tdap Vaccines Market Share (2016-2018)
Table Seqirus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seqirus DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Seqirus DTaP and Tdap Vaccines Market Share (2016-2018)
Table Merck Sharp & Dohme Corp Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Market Share (2016-2018)
Table Astellas Pharma US, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astellas Pharma US, Inc DTaP and Tdap Vaccines Market Share (2016-2018)
Table Pfizer Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Inc DTaP and Tdap Vaccines Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson DTaP and Tdap Vaccines Market Share (2016-2018)
Table Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent BioSolutions Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
